436 related articles for article (PubMed ID: 16836498)
1. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
2. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
3. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
4. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
Lawrence CM; Haniffa M; Dahl MG
Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
[TBL] [Abstract][Full Text] [Related]
5. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
6. Basal cell carcinomas: do they need to be followed up?
Park AJ; Strick M; Watson JD
J R Coll Surg Edinb; 1994 Apr; 39(2):109-11. PubMed ID: 7520063
[TBL] [Abstract][Full Text] [Related]
7. [Low 5-year recurrence rate after surgical excision of 126 basal cell carcinomas with frozen section analysis upon indication].
van der Meer GT; Willemse F; Marck KW
Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1409-13. PubMed ID: 11494691
[TBL] [Abstract][Full Text] [Related]
8. Do basal cell carcinomas recur after complete conventional surgical excision?
Griffiths RW; Suvarna SK; Stone J
Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
[TBL] [Abstract][Full Text] [Related]
9. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital.
Kyrgidis A; Vahtsevanos K; Tzellos TG; Xirou P; Kitikidou K; Antoniades K; Zouboulis CC; Triaridis S
Eur J Dermatol; 2010; 20(3):276-82. PubMed ID: 20406722
[TBL] [Abstract][Full Text] [Related]
10. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
Hamada S; Kersey T; Thaller VT
Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
[TBL] [Abstract][Full Text] [Related]
11. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
12. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
Hansen C; Wilkinson D; Hansen M; Soyer HP
Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
[TBL] [Abstract][Full Text] [Related]
13. The incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit.
Hussain M; Earley MJ
Ir Med J; 2003 Jan; 96(1):18-20. PubMed ID: 12617437
[TBL] [Abstract][Full Text] [Related]
14. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
15. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
[TBL] [Abstract][Full Text] [Related]
17. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
[TBL] [Abstract][Full Text] [Related]
18. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
[TBL] [Abstract][Full Text] [Related]
19. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
20. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]